Review
Oct 2026
Stage-specific quality of life and tolerability of CDK4/6 inhibitors in HR-positive/HER2-negative breast cancer: a narrative review.
Luca Scafuri, C. Buonerba, V. Marotta et al.
· Oncology · 0 citations